News

James Nachtwey Photographs Help Illustrate XDR-TB

This post originally appeared on CNN.com

By Patrice Poltzer for CNN

A mother comforts her young son who is suffering from TB meningitis.
A mother comforts her young son who is suffering from TB meningitis. Photo: James Nachtwey

LONDON, England — Many people think of tuberculosis as being a disease from the past. The truth is far from it: Tuberculosis is mutating into dangerous new strains for which there is no known cure.

One of the most frightening strains is XDR-TB, which stands for extensively drug-resistant TB.

Unlike less virulent strains, XDR-TB does not respond to the antibiotics that are usually used to treat TB. The disease is virtually incurable and threatens to become a pandemic.

About 40,000 new cases of XDR-TB emerge every year, the World Health Organization estimates.

Award-winning photojournalist James Nachtwey, who has chronicled the death and devastation the disease is bringing to many countries around the world, describes XDR-TB as “a merciless, man-eating predator lurking in the shadows.”

He warns: “If it’s not contained, the consequences could be dire.”

Nachtwey, who has been covering humanitarian crises for more than 30 years, was awarded a TED prize in 2007 which gave him $100,000 and one wish to change the world.

His wish centered on spreading awareness of this deadly form of TB and the images are borne out of Nachtwey’s frustrations with the underreporting of what is potentially a global health crisis.

> read the full post at CNN.com

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...